Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SL-901 |
Synonyms | |
Therapy Description |
Limited information is currently available on SL-901, a putative inhibitor of PI3K alpha and delta, and PIK3C2 beta (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SL-901 | SL901|SL 901 | PI3K Inhibitor (Pan) 40 | Limited information is currently available on SL-901, a putative inhibitor of PI3K alpha and delta, and PIK3C2 beta (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05382936 | Phase I | SL-901 | Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid Tumors | Completed | GBR | 0 |